Insider · CIK 0001875501

Mackay Sean

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001875501

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−25.7K sh	$0.67	−$17.3K	1,480,823
2026-06-20	LABSTANDARD BIOTOOLS INC.A Award	SVP & Chief Business Officer	AAward	+500K sh	—	—	1,506,552
2026-05-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−25.7K sh	$1.00	−$25.7K	1,006,552
2026-03-20	LABSTANDARD BIOTOOLS INC.A Award	SVP & Chief Business Officer	AAward	+272K sh	—	—	1,032,281
2026-03-20	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to buy)A Award	SVP & Chief Business Officer	AAward	+612K sh	—	—	612,240
2026-02-23	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−19.7K sh	$1.15	−$22.6K	760,174
2025-11-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−19.7K sh	$1.28	−$25.2K	779,835
2025-08-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−19.7K sh	$1.27	−$25K	799,496
2025-05-28	LABSTANDARD BIOTOOLS INC.F Tax Payment	SVP & Chief Business Officer	FTax Payment	−23.9K sh	$1.09	−$26.1K	819,157
2025-05-23	LABSTANDARD BIOTOOLS INC.S Sale	SVP & Chief Business Officer	SSale	−13.2K sh	$0.94	−$12.4K	843,076
2025-05-22	LABSTANDARD BIOTOOLS INC.S Sale	SVP & Chief Business Officer	SSale	−12.5K sh	$1.00	−$12.6K	856,293
2025-05-21	LABSTANDARD BIOTOOLS INC.S Sale	SVP & Chief Business Officer	SSale	−12.8K sh	$1.03	−$13.2K	868,829
2025-03-21	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	SVP & Chief Business Officer	AAward	+423K sh	—	—	422,500
2025-03-21	LABSTANDARD BIOTOOLS INC.A Award	SVP & Chief Business Officer	AAward	+282K sh	—	—	881,667
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−296K sh	—	—	0
2023-03-21	IsoPlexis CorpD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−914K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−48K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−24K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−112K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−14K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−14K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−52K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−834 sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−40K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−96K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−680K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−744K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−19K sh	—	—	0
2023-03-21	IsoPlexis CorpStock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−52K sh	—	—	0
2022-08-25	IsoPlexis CorpP Purchase	Director, Chief Executive Officer	PPurchase	+15K sh	$1.99	+$29.9K	914,366
2022-08-19	IsoPlexis CorpStock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−39.2K sh	—	—	834
2022-08-19	IsoPlexis CorpStock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−61K sh	—	—	19,000
2022-08-19	IsoPlexis CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+39.2K sh	$0.28	+$10.9K	838,366
2022-08-19	IsoPlexis CorpM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+61K sh	$0.28	+$17K	899,366
2022-03-31	IsoPlexis CorpStock OptionA Award	Director, Chief Executive Officer	AAward	+296K sh	—	—	296,100

Recent filings

Accepted (ET)
Aug 244
Mackay Sean0001193125-26-363767
SEC(opens sec.gov)
Jun 234
Mackay Sean0001193125-26-279833
SEC(opens sec.gov)
May 224
Mackay Sean0001193125-26-237182
SEC(opens sec.gov)
Apr 84
Mackay Sean0001193125-26-148614
SEC(opens sec.gov)
Feb 244
Mackay Sean0001193125-26-067638
SEC(opens sec.gov)
Nov 244
Mackay Sean0001193125-25-293841
SEC(opens sec.gov)
Aug 224
Mackay Sean0001193125-25-186506
SEC(opens sec.gov)
May 304
Mackay Sean0000950170-25-079890
SEC(opens sec.gov)
May 284
Mackay Sean0000950170-25-078463
SEC(opens sec.gov)
May 234
Mackay Sean0000950170-25-077191
SEC(opens sec.gov)
Mar 244
Mackay Sean0000950170-25-044011
SEC(opens sec.gov)
Mar 214
Mackay Sean0001062993-23-007401
SEC(opens sec.gov)

Companies

Address

C/O STANDARD BIOTOOLS INC. 50 MILK STREET, 10TH FLOOR

BOSTON, MA, 02109